Background and Objectives: There is inconsistent evidence about the potential influence of smoking on recovery from alcohol dependence. Our study aimed at assessing the impact of smokingbehavior on relapse during a 12 months follow-up period following a detoxification in patients with Alcohol Use Disorder (AUD). Methods: Three hundred Patients with AUD (74.9% smoking) were recruited from two inpatient detoxification units in psychiatric hospitals in Germany and their alcohol consumption was prospectively followed for 1 year. Data on different indicators of smoking behavior was gathered. Cox regression model was used to evaluate potential risk factors on time to relapse of alcohol consumption. Two hundred seventy-nine participants (n ¼ 279) were included in the final analysis. Results: Smoking increased the risk for alcohol relapse (hazard ratio ¼ 3.962, 95% CI 1.582-9.921). However, this increased risk is slightly reduced with higher numbers of daily consumed cigarettes (hazard ratio per cigarette ¼ .986, 95% CI .976-.995). Conclusion: Smoking reduced the probability of maintaining alcohol abstinence significantly, whereas higher number of cigarettes smoked daily diminished the increased risk of alcohol relapse in alcoholdependent patients. Scientific Significance: Coordinated psychiatric and substance abuse interventions for different subgroups of patients with AUD in the post-acute treatment phase are necessary. Individualized treatment planning is especially important in smoking patients with AUD who are vulnerable for a relapse to alcohol drinking and for somatic complications. Our findings might support individualized treatment plans. (Am J Addict 2017;26:366-373) 
INTRODUCTION
The strong positive association between consumption of alcohol and tobacco, the two drugs having a very high impact on the global burden of disease, has been confirmed by numerous studies in the past. 1 General population surveys demonstrate a trend of declining prevalence in smoking in industrialized countries. 2 In contrast, the smoking rate among treatment-seeking patients with alcohol-use disorders (AUD) remains stable at considerably higher proportions, exceeding even 75%. 3 Nicotine dependence is markedly increased in smokers with AUD and alcohol dependence is more frequent in smokers compared to non-smokers. 4 Furthermore, risky and/or harmful alcohol consumption occurs earlier in smokers 5 and variables related to nicotine dependence might serve as predictors of future alcohol dependence. 6 In this context, Green and Levy 7 have stated that "it is practically impossible to cure an alcoholic (or problem drinker) so long as he continues to smoke." Even though this issue has come under increased scrutiny, subsequent research has not provided a definitive answer as to whether smoking may undermine or support abstinence from alcohol in patients with AUD.
While there are studies that have detected detrimental effects of smoking on treatment outcomes in alcoholdependent patients, [8] [9] [10] [11] [12] [13] [14] there is also evidence that smoking does not pose a risk to sobriety in patients with AUD. 15, 16 In contrast to these findings, some studies either failed to detect a significant association between smoking and treatment outcomes, or reported mixed results. [17] [18] [19] These controversial findings and some methodological limitations in these studies (eg, study design, small sample sizes, low response rates, short follow up times) warrant further research on this topic.
Possible underlying mechanisms have also been discussed. Based on aspects of classical conditioning theory, there are two opposing hypotheses. First, the so-called priming hypothesis postulates that exposure to cues for either alcohol or tobacco could elicit craving for the alternate drug given a history of concurrent use. This may result in increased consumption of both substances and impede efforts in achieving abstinence in smoking patients with AUD. 20 In contrast, the coping hypothesis postulates that tobacco may decrease the risk of drinking for abstinent patients with AUD. 20 Pharmacological mechanisms may also contribute to explain a difference of risk of relapse between smoking and non-smoking alcohol-dependent patients. It was proposed from animal models that a dissimilar tendency to relapse between smoking and nonsmoking patients with AUD may originate from shared pharmacological actions of ethanol and nicotine. 21 The purpose of this paper is to prospectively examine the effect of smoking on treatment outcomes in a large sample of patients with AUD. Specifically, we investigated whether smoking status, intensity of smoking and severity of nicotine dependence predicted relapse to alcohol consumption over 1 year in adults with AUD, using a prospective study design.
METHODS
This study was designed and conducted in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by university institutional review boards and local Ethics Committee at the participating treatment centers. Written informed consent was obtained from all participants prior to participation in the study.
Sample
The participants of a two-center treatment study were used as the sample for this study. This treatment study was designed to evaluate the effect of a manualized psychoeducative intervention on the utilization of post-acute treatment following inpatient detoxification. Patients had been randomized to an intervention group receiving elements of motivational interviewing plus psychoeducation concerning alcohol dependence or to a mere detoxification (treatment as usual, TAU) condition. 22 Smoking habits were left untargeted in both interventions throughout hospitalization. Both treatment centers restricted indoor smoking to one designated room on the ward and allowed smoking outdoors. Male and female patients aged 18-65 underwent voluntary treatment and met criteria for alcohol dependence according the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition as well as according to the 2010 version of the International Classification of Diseases (ICD). Patients received clomethiazol or diazepam as needed and additionally levetiracetam, if there was a history of (withdrawal) seizures during in-patient detoxification. Patients were precluded from study enrollment, if they had (1) any additional Axis I diagnoses according to DSM-IV criteria, including concomitant abuse or dependence of substances other than alcohol or nicotine, (2) had a history of severe neurologic disease, (3) were intending to undergo psychotherapeutic or psychopharmacologic intervention, including relapse-preventing medication, (4) were planning to participate in post-acute treatment that had been arranged prior to admission, and (5) were of limited legal competence or had limited ability to give written informed consent. Between February 2009 and March 2013 a total of 300 subjects were recruited from two different treatment facilities. A total of 231 (77%) subjects were recruited at the Psychiatric University Hospital in Regensburg and 69 (23%) were recruited at the psychiatric hospital in Munich Haar. Due to item-wise missing values and an attrition rate of 96.7%, the effective sample size varies slightly over different statistical analyses, depending on the variables included in each model.
Measurements
During their inpatient stay for detoxification, demographic data, socioeconomic status, and psychiatric symptomatology were assessed using standardized and validated instruments. Alcohol and nicotine dependence were diagnosed using a computer-assisted version of the Munich-Composite International Diagnostic Interview (DIA-X/M-CIDI). 23 The data obtained from the participants were self-reported with the exception of a breathalyzer test and a urine drug screen to detect acute alcohol intake and consumption of illegal drugs. There is data supporting the hypothesis that selfreports regarding alcohol-intake are valid in abstinenceoriented treatment programs. 24 The use of questionnaires to assess smoking behavior were suitable for our study for several reasons: information could be collected retrospectively and provided information on long-term smoking behavior. A meta-analysis of studies that validated self-reported smoking behavior with biochemical measurements concluded that self reports of smoking status are generally accurate in most studies. 25 
Alcohol Use at Study Entry
Alcohol intake prior to treatment was assessed by Form 90, an instrument with good to excellent psychometric properties based on a timeline follow-back method. 26 By using this semistructured interview, daily drinking habits over the last 90 days were reconstructed, revealing weekly patterns, variability, and atypical periods of drinking. Daily amounts of alcohol consumed were calculated based on the self-reported information. A breathalyzer test and a urine drug screen were used to detect acute alcohol intake and consumption of illegal drugs at study entry.
Tobacco Use at Study Entry
Smoking status was determined by response to the question "are you currently smoking cigarettes?" Participants who had never used nicotine or who had not used this substance during the last 90 days prior to admission were considered nonsmokers, the remaining patients were considered smokers. Intensity of smoking was determined from participants' reported number of daily cigarettes. Total lifetime duration of smoking in years was based on self-reporting. The Fagerstr€ om Test for Nicotine Dependence (FTND) was administered to classify nicotine dependence with a score ranging from zero to ten. 27 As a stable non-smoker displays no dependence of nicotine, non-smokers were categorized to a score of zero.
Alcohol and Tobacco Use at Follow-up
Face-to-face follow-up interviews at 3, 6, and 12 months after discharge were conducted by trained personnel to reevaluate drinking and smoking behavior. Again, a Breathalyzer test and a urine drug screen were used at each follow-up interview to detect alcohol intake and consumption of illegal drugs. Drinking patterns were assessed by Form 90 and relapse was defined as any alcohol use since discharge from the facility's detoxification unit. Of the smoking indicators, only smoking status and FTND score were reevaluated at follow-up interviews.
Statistical Analysis
Cox proportional hazard model was used to evaluate potential risk factors (constant or time dependent patients' characteristics) on time to relapse of alcohol consumption. The assumption of proportional hazards over categories of independent variables was assessed numerically by calculating a new variable for each potential risk factor multiplying the natural logarithm of the time to relapse variable by the respective risk factor and incorporating this interaction variable into the statistical model. 28 Of the 12 variables tested, only being allocated to psychoeducative treatment did significantly interact with time to relapse. Therefore, the final Cox regression model was estimated stratified for treatment groups.
Model building used a backward selection procedure (pout ¼ .05) and a stepwise procedure (p-in ¼ .10; p-out ¼ .05) for variable selection resulting in the same subset of predictor variables.
Assuming for reasons of simplicity of calculations an effective sample size of n ¼ 289, given the observed proportion of relapses, and a type-I error rate of .05, statistical power was .79 to detect a risk ratio of a dichotomous predictor variable (like smoking status) of at least 1.6. An effect size like that one calculated from the final Cox model (HR ¼ 3.96 for smoking status) can be detected with power close to value 1.
Power calculations were performed using package powerSurvEpi in R.
RESULTS
Of the 300 patients enrolled, 290 patients could be reached for at least one of the follow-up interviews. Two hundred eighty-nine of them completed the final interview at 12 months. Only 10 patients (3.3%) missed all follow-up interviews. Data on timing of relapse nevertheless was available from other sources like general physicians (GPs). Thus, only item-wise non-response for variables explored as potential predictors of relapse reduced the sample size of the final multivariate statistical analysis to n ¼ 294 (98%).
Information on initial smoking status was obtained from 299 patients and revealed that the majority was smoking (74.9%). Among the non-smokers, 34 patients reported to be ex-smokers and 35 patients reported to be lifetime nonsmokers. Smoking rate at the 12-months interview was 76.4%. The distribution of demographic characteristics between smoking and non-smoking patients is presented in Table 1 . Smokers had a mean FTND score of 5.6 (SD ¼ 2.3), and had been smoking for a mean duration of 25.8 (SD ¼ 10.7) years.
Proportion of initial smokers versus initial non-smokers relapsing to alcohol consumption over time is illustrated through the Kaplan-Meier estimate of the survival function in Figure 1 . As can be seen, initial smokers experienced relapse slightly earlier (median survival time about 150 d vs about 180 d) and more frequent. Therefore, Table 2 gives the results of the initial multivariate cox regression analysis including demographic characteristics as well as all smoking indicators. The coefficients model the change in probability of staying abstinent over time. In particular, positive coefficients accelerate the relapse process, negative coefficients slow down this process. In-patient post-acute treatment was considered as a time-dependent covariate whose value switches from zero to one at the time, when an in-patient abstinence oriented treatment was initiated.
Of the 12 tested variables, four were identified as significant predictors of time to first relapse. Patients living in a private housing situation displayed higher chances to remain abstinent than other living situations (eg institutionalized living). Patients who were smokers at treatment entry and patients with higher FTND scores had an increased risk for alcohol relapse. However, higher number of cigarettes smoked daily were associated with slightly delayed (or avoided) relapse in alcoholdependent patients. Differences in number of years smoked could not be shown to contribute additionally to the forecast of Table 3 . A parsimonious model of the relapse process is therefore given by living situation, in-patient post-acute specialized treatment of dependence, and two different aspects of nicotine consumption: the mere smoking status predicts a higher risk for relapse to alcohol, but smoking larger numbers of cigarettes per day mitigates this negative effect. An additional analysis showed that differentiating between ex-smokers and lifetime non-smokers among the group of non-smoking patients had no effect on the above mentioned results. Due to the character of the proportional hazard model, the impact of significant predictor variables on the relapse process at a certain time t is dependent on the respective hazard function at the same time. In Figure 1 , it can be seen that during the first 2 months after acute treatment the relapse risk was highest.
DISCUSSION

Key Findings
The primary finding of our analysis shows that baseline smoking status at the beginning of alcohol abstinence was associated with drinking outcomes in alcohol-dependent patients. Compared with non-smokers, smokers had a significantly higher risk to relapse to alcohol drinking within the first 12 months after detoxification. However, this increased risk seems to be slightly reduced with higher numbers of daily consumed cigarettes. While additional variables related to smoking-behavior such as FTND score and duration of smoking in years did not add information on the chances of alcohol relapse, post-acute treatment condition, and housing situation were shown to modify the risk of relapse to alcohol-dependence. Though effect size could only be estimated with partly large CI (meaning that it is difficult to quantify the "real" increase in risk), nevertheless power and significance level were both satisfying to identify relevant prognostic variables.
Comparison to Previous Research
Among trials examining the effect of smoking indicators on the risk or extent of relapse to alcohol use, our results are in line with most of the other studies published on this topic. [8] [9] [10] [11] [12] [13] [14] In contrast to our findings, there are studies that detected mainly positive effects of smoking status on treatment outcomes in alcohol-dependent patients. 15, 16 Some of the conflicting data could be due to different methodological approaches in the original study designs, which also limit comparability between these studies and ours. Outcome measures differed in Toneatto who used the number of abstinent days as a parameter defining treatment success. Compared to the other studies mentioned above, Schmidt and Smolka used a relatively short follow-up period of 24 weeks, which might have obscured their findings. Furthermore, it is possible that low response rates in Toneatto (51%) influenced the accuracy of the results in this study.
There are also studies that failed to detect a significant association between baseline smoking status and treatment outcomes. [17] [18] [19] Compared to our analysis, these studies had smaller sample sizes and may have been underpowered to reveal statistically significant effects. However, these three studies did not only examine the effect of baseline smoking status, but also included other smoking variables in their analyses. Miller et al 19 showed that relapse to smoking by pretreatment non-smokers was associated with non-remission of alcohol abuse. The results in Gulliver (2000) indicate that among patients who relapsed to alcohol, those who smoked more cigarettes per day drank less frequently.
Possible Mechanisms
Our results illustrate the complex relationship between smoking and drinking behavior. Different underlying and interacting factors may be considered when interpreting our findings. Pharmacological mechanisms may also contribute to explain why smoking reduces chances of alcohol abstinence. In rats, nicotine served as an effective stimulus for reinstatement of alcohol seeking behavior in drug-free periods, especially if the animals were exposed to nicotine concomitantly during prior alcohol self-administration training. 21 The underlying mechanisms in the mesolimbic reward system, presumably involved in mediating this effect, are increasingly being unveiled. 29, 30 Major knowledge gaps remain despite the headway. The exact role of these pharmacological interactions and their possible influences on the risk of relapse in smokers with AUD still has to be elucidated.
The theoretical model of the priming hypothesis states that smoking might be associated with a higher risk to alcohol relapse due to cue reactivity. Previous clinical trials support this concept, showing that concomitant use of alcohol and nicotine increases craving for both substances. 31 Furthermore, alcohol-dependent patients who smoke reported less alcohol consumption and lower urges to drink on non-smoking days. 32 However, according to our results, this correlation is not straightforward, since this increased risk seems to be slightly reduced with higher numbers of daily consumed cigarettes. Even though there has been some critical reception of the coping theory, 33 it might be possible that patients also use smoking as a means to deal with urges to drink and thus experience high cravings to smoke. Smoking a higher number of cigarettes might help heavy smokers to overcome not only neurocognitive deficits after chronic alcohol consumption, 34 but also the cue-induced craving for alcohol, usually leading to increased relapse risk.
Our results show that patients in institutionalized living are more likely to relapse. Institutionalized living might probably indicate a longer history of dependence having experienced stronger social consequences such as loss of private housing, and therefore describing patients with worse prospects of abstinence.
Strengths and Limitations
Compared to previous studies, our study has several strengths. To our knowledge, we are the first study to investigate in detail the influence of different indicators of smoking behavior on the odds of alcohol relapse in patients with AUD. We utilized a prospective study design and achieved an overall sound response rate. Only three of the previous studies had sample sizes larger than ours. 9, 11, 14 Furthermore, the measures used to assess smoking intensity and alcohol consumption are valid and reliable. 26, 27 With regards to both percentage of women and smokers (33.8% and 74.9%, respectively), our study sample accurately represents the general population of alcohol-dependent patients. 3 Our study also has some limitations that should be mentioned. First, the data obtained from the participants were self-reported with the exception of a breathalyzer test and a urine drug screen to detect acute alcohol intake and consumption of illegal drugs. No biological measures to verify smoking (such as breath expired carbon monoxide or salivary or blood levels of cotinine) were used at study entry or at follow-up interviews. Therefore, the data might have been subject to intentional as well as unintentional measurement error. But methodological studies so far have resulted in high concordance between self-reporting and objective measures, 24 at least for consumption behavior. Moreover, there were no negative consequences associated with honest reports of alcohol intake, which often lead to distorted data. Despite the aforementioned advantages, concerns remain as for example, the quantity of inhaled and absorbed smoking products varies with the manner of smoking, which may be difficult to express and quantify in a questionnaire. 35 Second, only parts of the baseline smoking indicators were reassessed during follow-up interviews. Quitters and stayers of smoking behavior could not be measured during the follow-up interviews with sufficient response rate for exactly these variables. Consequently, we were not able to determine the potential impact of changes in smoking variables on abstinence from alcohol. Moreover, we did not address drinking goals of our patients. Drinking goals may be dynamic (eg, patients may not have a fixed drinking goal in mind upon entering treatment or may change their goal throughout treatment or follow-up phase). Based on the abstinence-only outcome measure, we might have failed to identify successful treatment outcomes among patients who reduced drinking in a manner consistent with their individual treatment goal. Third, participation in a trial of psychoeducative intervention might reduce generalizability of our results. Finally, not all variables that have been shown to mitigate the risk of drug relapse in previous research have been included in our study (eg, behavioral changes such as physical activity). Although we included several relevant variables in our study, number of cigarettes could have been associated with a variable also relating to alcohol relapse which was not included in our model. Possibly, number of cigarettes smoked may be a proxy for other patient characteristics, in that, for example, patients with a higher level of stress may be smoking a higher number of cigarettes. 36 
Implications for Future Research and Clinical Practice
Despite the aforementioned limitations, our prospective study in 300 patients has enough statistical power to show that smokers with AUD have a significantly higher risk of relapse to alcohol after detoxification than non-smoking patients with AUD. However, our study was not designed to address the possible causal relationship between smoking and the probability of relapse in patients with AUD. Although we found an association between smoking indicators and risk of relapse, it is up to future research to investigate the underlying causal mechanisms behind this statistical association. With regards to priming or coping hypothesis, it would be helpful to elucidate the exact patterns of smoking and drinking behavior (eg, if patients smoke before drinking, during drinking, or after drinking). To improve accuracy of smoking-related parameters, physiological measurement of biomarkers should be included in future study designs.
Efforts in offering smoking cessation programs to patients with AUD in recovery are gradually gaining momentum and the majority of studies on this topic found that such interventions might not pose a risk to sobriety. 37, 38 However, success rates in smoking cessation treatment during recovery from alcoholism remain relatively low 39 and the best timing for the initiation of such programs is unclear. 33, 37 CONCLUSION According to our results, smokers compose a subgroup of patients with AUD highly vulnerable to relapse to alcohol. This negative effect outweighs the small positive effect that smoking higher numbers of cigarettes might have on the course of abstinence. Given these results and the fact that alcohol-dependent patients who smoke are at high risk for somatic complications, 40, 41 special considerations and individualized treatment planning is necessary for these patients. Although the topic warrants future research to determine the need, implementation, and best point for smoking cessation programs during alcohol treatment, our results may be used to improve these type of individualized treatment plans.
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